Analgesics Alcohol Warning Required By April 23 In Final Rule
This article was originally published in The Tan Sheet
Executive Summary
FDA will allow OTC analgesic manufacturers to use stick-on labels initially to comply with its Oct. 23 final rule mandating organ-specific alcohol warnings on all OTC adult analgesics/antipyretics.
You may also be interested in...
Naproxen Directly Linked To GI Bleeding In 32% Of Cases Reviewed By FDA
Nearly one-third of gastrointestinal hemorrhage cases related to OTC naproxen sodium use did not involve additional risk factors, FDA reports in a recently released postmarketing safety review
Naproxen Directly Linked To GI Bleeding In 32% Of Cases Reviewed By FDA
Nearly one-third of gastrointestinal hemorrhage cases related to OTC naproxen sodium use did not involve additional risk factors, FDA reports in a recently released postmarketing safety review
OTC Analgesic Toxicity Review Expected By Fall – FDA
FDA plans to review the potential toxicity risks of all OTC analgesics at an upcoming advisory committee meeting, the agency said